Oxford Brain Diagnostics has appointed Jieun Choe as Chief Executive Officer as the company embarks on a pivotal growth stage. With her extensive experience, Choe aims to establish quantitative brain biology as a new standard for precision brain health.
Company Information
Company
Oxford Brain Diagnostics
Location
Oxford, England, United Kingdom
About
Oxford Brain Diagnostics (OBD) is a pioneer in quantitative brain biology, focused on advancing brain health through objective measurement. Developed from over a decade of research at the University of Oxford, its patented technology transforms MRI into objective measures of brain microstructure. The company is dedicated to improving the diagnosis, treatment selection, and development of therapies for neurodegenerative diseases.
Don't miss Oxford Brain Diagnostics's next move
Get an email the moment Oxford Brain Diagnostics changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Oxford Brain Diagnostics's next move